Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H R Peeters

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Nederlands Tijdschrift Voor Geneeskunde|June 5, 2001
[Persistent infiltrative pulmonary disease]B Boersema, H R Peeters, J M Broekman, et al.
Clinical Rheumatology|September 1, 1995
Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic diseaseM Jongen-Lavrencic, H R Peeters, G Vreugdenhil, et al.
Annals of the Rheumatic Diseases|October 1, 1996
Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trialH R Peeters, M Jongen-Lavrencic, G Vreugdenhil, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 1998
[Pain in the hip area accompanied by a fever]B A Veldman, H R Peeters, H J Teertstra, et al.
Rheumatology International|January 1, 1994
R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritisM Jongen-Lavrencic, H R Peeters, B Backx, et al.
The Journal of Rheumatology|August 1, 1997
Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic diseaseM Jongen-Lavrencic, H R Peeters, A Wognum, et al.
Rheumatology International|July 10, 1999
Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measuresH R Peeters, M Jongen-Lavrencic, C H Bakker, et al.
Annals of the Rheumatic Diseases|March 1, 1996
Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onsetH R Peeters, M Jongen-Lavrencic, A N Raja, et al.
Clinical and Experimental Immunology|February 1, 1996
IL-6-induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammationsM Jongen-Lavrencic, H R Peeters, H Rozemuller, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Nederlands Tijdschrift Voor Geneeskunde|June 5, 2001
[Persistent infiltrative pulmonary disease]B Boersema, H R Peeters, J M Broekman, et al.
Clinical Rheumatology|September 1, 1995
Interaction of inflammatory cytokines and erythropoeitin in iron metabolism and erythropoiesis in anaemia of chronic diseaseM Jongen-Lavrencic, H R Peeters, G Vreugdenhil, et al.
Annals of the Rheumatic Diseases|October 1, 1996
Effect of recombinant human erythropoietin on anaemia and disease activity in patients with rheumatoid arthritis and anaemia of chronic disease: a randomised placebo controlled double blind 52 weeks clinical trialH R Peeters, M Jongen-Lavrencic, G Vreugdenhil, et al.
Nederlands Tijdschrift Voor Geneeskunde|September 30, 1998
[Pain in the hip area accompanied by a fever]B A Veldman, H R Peeters, H J Teertstra, et al.
Rheumatology International|January 1, 1994
R-h-erythropoietin counteracts the inhibition of in vitro erythropoiesis by tumour necrosis factor alpha in patients with rheumatoid arthritisM Jongen-Lavrencic, H R Peeters, B Backx, et al.
The Journal of Rheumatology|August 1, 1997
Elevated levels of inflammatory cytokines in bone marrow of patients with rheumatoid arthritis and anemia of chronic diseaseM Jongen-Lavrencic, H R Peeters, A Wognum, et al.
Rheumatology International|July 10, 1999
Recombinant human erythropoietin improves health-related quality of life in patients with rheumatoid arthritis and anaemia of chronic disease; utility measures correlate strongly with disease activity measuresH R Peeters, M Jongen-Lavrencic, C H Bakker, et al.
Annals of the Rheumatic Diseases|March 1, 1996
Course and characteristics of anaemia in patients with rheumatoid arthritis of recent onsetH R Peeters, M Jongen-Lavrencic, A N Raja, et al.
Clinical and Experimental Immunology|February 1, 1996
IL-6-induced anaemia in rats: possible pathogenetic implications for anemia observed in chronic inflammationsM Jongen-Lavrencic, H R Peeters, H Rozemuller, et al.
Pageof 1